Significantly increased serum concentrations of soluble VCAM-1 have been noted in patients with gestational diabetes mellitus (GDM) and type 1 diabetes (T1D) compared with the control group [121,122,123,124]. Here, VCAM1 is linked to type 1 diabetes mellitus.